Blood test and phone app aim to get more texans screened for colon cancer
NCT ID NCT07398456
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will enroll 5,500 average-risk adults in Texas to see if offering a blood test for colorectal cancer, along with an educational smartphone app, increases screening rates. Participants can choose the blood test, and some will get the app to help them follow up. The goal is to understand if this approach makes screening more acceptable and leads to more people completing recommended follow-up tests.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Blood-based screening test (BBST) and educational smartphone app
What this could lead to
If successful, this could show that a simple blood test and app reminders make colorectal cancer screening easier and more acceptable, potentially catching cancer earlier.
What could go wrong
This is an early implementation study, not testing a new treatment. It may not prove that the blood test reduces cancer deaths, and results may not apply to other populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER (CRC) SCREENING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Baylor University Medical Center, Baylor Charles A Sammons Cancer Center
Dallas, Texas, 75246, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact